PainNewsNetwork ‘Opioid of the Future’ Postponed

By: Pat Anson, PNN Editor 7/26/19 The U.S. Food and Drug Administration is tapping the brakes on NKTR-181, an experimental opioid pain medication that has less abuse potential than traditional opioids like oxycodone or hydrocodone. In an SEC filing, Nektar Therapeutics said it received a letter from the FDA on July 23 saying the agency…

Chronic Pain Management Strategies

CERGM Citizens for Ethical Reforms in Government and Medicine 7/19/2019 By R Carter Not a week goes by anymore that I’m not reading about another death in the chronic pain community, a results of forced tapers, discharged from a practice, loss of a prescriber for other reasons, followed by an inability to find a new…